Browsing: Q3FY23 results

JB Pharma’s revenue jumped to INR 793 crores, and Profit after Tax stood at Rs. 106 crore as compared to Rs. 84 crore registering a growth of 26%

SVP Global has improved in operations with substantial improvement in EBITDA margins even after very high raw cotton prices.